HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2017 | $18.9 M |
2018 | $14.3 M |
Total: | $33.2 M |
Period | Weight, tons. |
---|---|
2017 | 78.2 |
2018 | 103 |
Total: | 181 |
Group product | 2017 | 2018 | Ch. | ∑ (2017-2018) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | $181 K | $635 K | 251% | $816 K | 2.5% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | $18.8 M | $13.7 M | 27% | $32.4 M | 97.5% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | $18.9 M | $14.3 M | $33.2 M |
№ | Country | ∑ (2017-2018) | Ratio |
---|---|---|---|
1 | Germany | $4.01 B | 22.8% |
2 | France | $1.61 B | 9.1% |
3 | Italy | $1.2 B | 6.8% |
4 | United States | $1.1 B | 6.3% |
5 | India | $966 M | 5.5% |
6 | United Kingdom | $957 M | 5.4% |
7 | Switzerland | $920 M | 5.2% |
8 | Ireland | $714 M | 4.1% |
9 | Spain | $485 M | 2.8% |
10 | Netherlands | $463 M | 2.6% |
11 | Austria | $462 M | 2.6% |
12 | Hungary | $448 M | 2.5% |
13 | Belgium | $414 M | 2.4% |
14 | Slovenia | $305 M | 1.7% |
15 | Puerto Rico | $297 M | 1.7% |
... | ... | ... | ... |
38 | Greece | $36.9 M | 0.2% |
39 | Malta | $34.6 M | 0.2% |
40 | Thailand | $33.2 M | 0.2% |
41 | Iran | $27.4 M | 0.2% |
42 | Jordan | $21.6 M | 0.1% |
... | ... | ... | ... |
The total for all countries: | $17.6 B | 100% |
№ | Region | ∑ (2017-2018) | Ratio |
---|---|---|---|
1 | Moskva | $33.2 M | 99.9% |
2 | Sankt-Peterburg | $20.1 K | 0.1% |
By all regions: | $33.3 M | 100% |